AML MRD Utility in New Drug Development - Clinical Perspectives, Assay Principles, Method Validation and Technologies

Do you want to gain a deeper understanding of measurable residual disease evaluation of AML by multiparameter flow cytometry and how you can implement and utilize this assay in your laboratory? In this webinar, we will discuss, from three unique yet complimentary perspectives, AML MRD utility in new drug development, assay principles & trial validations, and tools & technologies for flow cytometry.